GBR 13098
GBR 13098 is a dopamine transporter inhibitor with a rat IC50 of 43 nM, and exhibits dopaminergic activity in vivo.GBR 13098 selectively blocks dopamine uptake, increasing synaptic dopamine availability, with weaker activity against norepinephrine uptake.GBR 13098 induces ipsilateral circling in lesioned rats and increases locomotor activity in naive mice and habituated rats, with effects attenuated by dopamine receptor antagonism.GBR 13098 reduces DOPA formation in dopamine-rich brain regions and enhances inhibitory responses of substantia nigra zona compacta dopamine neurons to dopamine.GBR 13098 serves as a tool for studying dopaminergic systems.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 77862-94-3
- 分子式: C30H39F3N2O7S2
- 分子量:660.77
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
GBR 13098 (2.5-10.0 mg/kg; i.p.) produces dose-dependent ipsilateral rotational behavior in 6-hydroxydopamine-lesioned female Sprague-Dawley rats, with the highest cumulative 6-hour response (1,683 turns) at the 10.0 mg/kg i.p. dose, and this effect is dopamine receptor-mediated[1].
GBR 13098 (5-20 mg/kg; i.p.) produces dose-dependent increases in locomotor activity in healthy male Swiss-Webster mice, with a robust response at the 20 mg/kg i.p. dose, and this activity is mediated by dopamine receptors[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Swiss-Webster (male, 25-30 g)[1]
-
Dosage:5 mg/kg; 10 mg/kg; 20 mg/kg
-
Administration:i.p.
-
Result:Caused a slight increase in locomotor activity at 5 and 10 mg/kg doses.
Caused a large increase in locomotor activity at 20 mg/kg dose, which persisted for the full 1.5-hour measurement period.
Greatly attenuated locomotor activity increase when mice were pretreated with haloperidol (0.05-1.0 mg/kg).
-
Animal Model:Sprague-Dawley (female, 150-175 g, unilateral 6-hydroxydopamine lesion of the left nigrostriatal pathway, selected for ≥500 ipsilateral turns in 2 hours following amphetamine injection)[1]
-
Dosage:2.5 mg/kg; 5.0 mg/kg; 10.0 mg/kg
-
Administration:i.p.
-
Result:Induced cumulative 6-hour ipsilateral turns of 211 at 2.5 mg/kg.
Induced cumulative 6-hour ipsilateral turns of 459 at 5.0 mg/kg.
Induced cumulative 6-hour ipsilateral turns of 1,683 at 10.0 mg/kg.
Sustained rotational behavior for the full 6-hour measurement period.
Greatly attenuated ipsilateral rotation when rats were pretreated with haloperidol.
-
Animal Model:Sprague-Dawley (male, 200-300 g)[2]
-
Dosage:10 mg/kg; 20 mg/kg; 40 mg/kg (i.p.); 0.1 mg/kg; 2 mg/kg; 20 mg/kg (i.v.); 20 mg/kg (i.p., 10-30 min prior to microiontophoresis)
-
Administration:i.p.; i.v.; 10-30 min prior to microiontophoresis
-
Result:Caused a marked increase in spontaneous locomotor activity, with a maximal >1500% increase observed 45-60 minutes after 20 mg/kg (i.p.).
Induced a relatively high degree of stereotypies at 40 mg/kg (i.p.).
Had its locomotor stimulation at 20 mg/kg (i.p.) almost totally prevented by pretreatment with haloperidol or reserpine.
Reduced DOPA formation in the striatum and limbic region at 20 mg/kg (i.p.), but had no effect on dopamine-poor hemispheres.
Did not alter the spontaneous firing rate of most substantia nigra zona compacta dopamine neurons at 0.1-20 mg/kg (i.v.) or 20 mg/kg (i.p.); only 2 of 16 cells showed a slight (~20%) reduction in firing rate 30 minutes after 20 mg/kg (i.v.).
Enhanced the inhibitory response of dopamine neurons to microiontophoretically applied dopamine at 20 mg/kg (i.p., 10-30 min), increasing maximal inhibition from 37% to 65% of spontaneous firing rate, but did not affect the inhibitory response to microiontophoretically applied GABA.
化学情報
-
CAS 番号 77862-94-3
-
分子量 660.77
-
分子式 C30H39F3N2O7S2
-
SMILES
CS(=O)(O)=O.CS(=O)(O)=O.FC1=CC=C(CCCN2CCN(CCOC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)CC2)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Heikkila RE, et al. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. European journal of pharmacology. 1984 Aug 17;103(3-4):241-8. [Content Brief]
[2]. Pileblad E, et al. GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies. Naunyn-Schmiedeberg's archives of pharmacology. 1986 Dec;334(4):383-7. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
GBR 13098 関連分類
HY-183482 関連分類
Powered by Bioz
Keywords